Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Other Non-Current Assets (2017 - 2025)

Acro Biomedical has reported Other Non-Current Assets over the past 9 years, most recently at $4600.0 for Q2 2025.

  • Quarterly results put Other Non-Current Assets at $4600.0 for Q2 2025, changed 0.0% from a year ago — trailing twelve months through Jun 2025 was $4600.0 (changed 0.0% YoY), and the annual figure for FY2024 was $4600.0, changed 0.0%.
  • Other Non-Current Assets for Q2 2025 was $4600.0 at Acro Biomedical, roughly flat from $4600.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for ACBM hit a ceiling of $4600.0 in Q4 2023 and a floor of $4230.0 in Q2 2021.
  • Median Other Non-Current Assets over the past 5 years was $4415.0 (2021), compared with a mean of $4415.0.
  • Biggest five-year swings in Other Non-Current Assets: changed 0.0% in 2021 and later grew 8.75% in 2023.
  • Acro Biomedical's Other Non-Current Assets stood at $4230.0 in 2021, then changed by 0.0% to $4230.0 in 2022, then grew by 8.75% to $4600.0 in 2023, then changed by 0.0% to $4600.0 in 2024, then changed by 0.0% to $4600.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $4600.0 (Q2 2025), $4600.0 (Q1 2025), and $4600.0 (Q4 2024) per Business Quant data.